Delivery Order SPE2DB20D3101-SPE2DB25FRNC9
Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $4.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, for the supply of Actemra 162 mg/0.9 mL syringes valued at $4,594.53. This firm fixed-price, competitively awarded delivery order is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency, and has an ultimate completion date of August 13, 2025. The award was made under no set-aside designation,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,660.75 by the Defense Logistics Agency (DLA) on August 1, 2025. The contract, which is not set-aside and competitively awarded under a firm fixed-price structure, calls for delivery of Actemra Actpen 162 mg/0.9 mL injectable medication with a completion date of August 4, 2025. The place of performance is the company's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order valued at $4,939.02 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, utilizes firm fixed price pricing with no set-aside designation, indicating competitive award through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $11,336.48 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 ml syringes, with a completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a direct fulfillment order under AmerisourceBergen's broader contract vehicle with DLA. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Actemra 162 mg/0.9 ml syringes valued at $7,762.59 with firm fixed pricing. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's existing contract vehicle with the DLA. This delivery order is...
- On September 19, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $38,572.76 to supply Actemra 200 mg/10 mL vials. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of September 22, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order on June 2, 2025, by the Defense Logistics Agency to supply ACTEMRA 162 mg/0.9 mL syringes valued at $3,760.51 with a completion date of June 3, 2025. The contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,877.84 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of June 27, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office location. This delivery order is issued under the company's broader...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,490.23, is a delivery order for the pharmaceutical product ACTEMRA 400 MG/20 ML VIAL 20ML. The contract has an ultimate completion date of April 14, 2025 and is a firm fixed price contract. AmerisourceBergen has established itself as a key vendor for federal healthcare programs, particularly...
- AmerisourceBergen Drug Corp was awarded a $9,151.52 firm fixed-price delivery order by the Defense Logistics Agency on September 26, 2025, for the supply of Actemra ActPen 162 mg/0.9 ml injectable medication. This is a non-set-aside competitive award with an ultimate completion date of September 29, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...